10/22/2026
Natural kratom and dangerous, enhanced opioid products are NOT the same.
HHS is following the science and drawing a clear line between the two.
HHS' new recommendation gives Drug Enforcement Administration - DEA precise, science-based thresholds to target concentrated 7-OH and MGPI products without sweeping natural botanical kratom into Schedule I.